Frequency and Cost of Chemotherapy-Related Serious Adverse Effects in a Population Sample of Women With Breast Cancer

Background: The number, nature, and costs of serious adverse effects experienced by younger women receiving chemotherapy for breast cancer outside of clinical trials are unknown. Methods: From a database of medical claims made by individuals with employer-provided health insurance between January 19...

Full description

Saved in:

Bibliographic Details
Published in:	JNCI : Journal of the National Cancer Institute Vol. 98; no. 16; pp. 1108 - 1117
Main Authors:	Hassett, Michael J., O'Malley, A. James, Pakes, Juliana R., Newhouse, Joseph P., Earle, Craig C.
Format:	Journal Article
Language:	English
Published:	Cary, NC Oxford University Press 16-08-2006 Oxford Publishing Limited (England)
Subjects:	Adult Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - economics Biological and medical sciences Breast cancer Breast Neoplasms - drug therapy Breast Neoplasms - economics Chemotherapy Drug toxicity and drugs side effects treatment Emergency medical care Emergency Service, Hospital - utilization Female Health Care Costs Health care expenditures Health insurance Humans Insurance Claim Review Logistic Models Medical sciences Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) Odds Ratio Patient Admission - statistics & numerical data Patient admissions Pharmacology. Drug treatments Side effects Tumors United States United States North America America Human Antineoplastic agent Costs Toxicity Breast cancer Malignant tumor Mammary gland diseases Chemotherapy Cancerology Treatment Health economy Secondary effect Adult Complication Female Frequency Economic aspect
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!